-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Tg Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2011 to Q3 2025.
- Tg Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was -$365M, a 94169% decline year-over-year.
- Tg Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was -$360M.
- Tg Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $2.21M, a 467% increase from 2023.
- Tg Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $390K.
- Tg Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)